Robeco Institutional Asset Management
GHDX

Robeco Institutional Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Robeco Institutional Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,400
Closed -$198K – 1015
2019
Q2 		$198K Sell
3,400
-187,824
-98% -$11.1M ﹤0.01% 913
2019
Q1 		$13.4M Buy
191,224
+44,488
+30% +$3.3M 0.05% 417
2018
Q4 		$9.41M Buy
+146,736
New +$10.3M 0.04% 420

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Robeco Institutional Asset Management's GHDX Position: Q3 2019 in Review

Robeco Institutional Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 3,400 shares — an estimated $198K sold.

Robeco Institutional Asset Management first reported a position in GHDX in Q4 2018 and held it in 3 quarters. The position peaked at $13.4M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Robeco Institutional Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 3,400 Genomic Health, Inc. shares in Q3 2019, an estimated $198K.
  • Robeco Institutional Asset Management first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 3 quarters.
  • Robeco Institutional Asset Management's Genomic Health, Inc. position peaked at $13.4M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.